Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Similar documents
Overview of drug-induced deaths in Europe - What does the data tell us?

Trends in injecting drug use in Europe

Smokefree Policies in Europe: Are we there yet?

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

New trends in harm reduction in Europe: progress made challenges ahead

Cross Border Genetic Testing for Rare Diseases

Perspectives for information on alcohol use in the EU

Project Meeting Prague

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Underage drinking in Europe

Present and potential perspectives for information on alcohol use in the EU

Engagement in language assessment / Regions of Europe

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Where we stand in EFORT

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Monthly measles and rubella monitoring report

Outcome of proficiency test on EIA serology

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

The health economic landscape of cancer in Europe

European Community Pharmacy: a reference in Public Health

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Alcohol-related harm in Europe and the WHO policy response

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

European Collaboration on Dementia. Luxembourg, 13 December 2006

UK bowel cancer care outcomes: A comparison with Europe

Where do EU Contries set the limit for low risk drinking.

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

real-time AQ data 2007 and plans for 2008

Q1 What age are you?

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

LEBANON. WCPT COUNTRY PROFILE December 2018

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

DENMARK. WCPT COUNTRY PROFILE December 2018

Nutrient profiles for foods bearing claims

The cancer burden in the European Union and the European Region: the current situation and a way forward

Identifying Europe s information needs for effective drug policy Lisbon, EMCCDA

Correction to: The education gradient in cancer screening participation: a consistent phenomenon across Europe?

CNAPA Meeting Luxembourg September 2016

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

GERMANY. WCPT COUNTRY PROFILE December 2018

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

European status report on alcohol and health Leadership, awareness and commitment

European Status report on Alcohol and Health

Post-test of the advertising campaign Help

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Alcohol Prevention Day

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Critical immunity thresholds for measles elimination

Alcohol related harms to children and youth and ways to address it Case of Finland

Real Life, Real PD Survey

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

The Identification of Food Safety Priorities using the Delphi Technique

Expert Peer Review for Carfentanil

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Screening for Cervical Cancer in Europe

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Rheumatoid Arthritis Disease Burden and Access to Treatment

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Table 7.1 Summary information for lung cancer in Ireland,

Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon?

Table 6.1 Summary information for colorectal cancer in Ireland,

CND UNGASS FOLLOW UP

G u a r d i a C i v i l Agrupación de Tráfico. Alcohol, the effectiveness of enforcement

Extrapolation and potential impact of IPHS deployment in Europe

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Transmission, processing and publication of HBS 2015 data

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

L 322/24 Official Journal of the European Union

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

Review of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

Cups & Filters. 2.5ml sterile cup 100 pcs bag 100 and more Handle. Cotton filter 1000 pcs carton 5000 and more

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

SOITC Press Ad FAQs. Q: When will these Terms and Conditions changes come into effect?

Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity

Transcription:

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon, 24.9.2013

Route of administration of clients entering treatment by primary drug, 2010 or most recent year available all opioid outpatient clients by country and usual route of administration (%) Source: EMCDDA Stats Bull 2012 TDI 17/2 Country Inject Smoke/inhale Route of administration of opioids Eat/drink 11 Sniff Others Austria 34,7 6,5 17,9 40,8 0,0 Belgium 1 20,6 63,7 12,8 2,7 0,2 Bulgaria 81,8 4,6 0,9 7,4 5,2 Cyprus 64,1 29,9 3,2 2,8 0,0 Czech Republic 79,3 7,4 8,9 4,2 0,1 Denmark 15,6 19,5 58,8 6,1 0,0 Estonia 2 86,5 11,4 1,3 0,8 0,0 Finland 74,7 0,5 16,7 8,1 0,0 France 22,8 14,1 9,3 52,9 0,9 Germany 35,8 17,0 39,7 6,6 1,0 Greece 38,0 10,5 0,9 50,5 0,0 Hungary 69,3 15,2 11,7 3,9 0,0 Ireland 32,0 60,9 7,0 0,1 0,0 Italy 3 53,3 35,3 1,9 8,7 0,8 Latvia 4 93,5 0,3 5,5 0,7 0,0 Lithuania : : : : : Luxembourg 68,4 30,5 0,0 0,0 1,1 Malta 5 61,2 30,9 0,4 5,8 1,7 Netherlands 6 7,0 77,3 13,4 2,4 0,0 Poland 7 66,2 29,2 4,2 0,4 0,0 Portugal 8 14,5 84,1 0,9 0,4 0,1 Romania 91,4 6,9 1,0 0,8 0,0 Slovakia 78,0 12,4 3,5 6,0 0,0 Slovenia 51,9 35,0 2,5 10,6 0,0 Spain 9 16,4 71,1 5,1 6,0 1,4 Sweden 58,5 11,3 27,6 2,3 0,3 UK 10 33,5 54,9 10,0 0,9 0,7 Croatia 73,4 5,2 1,5 19,9 0,0

Route of administration of heroin of clients entering outpatient treatment in Austria in 2012 (n = 1.177) 70% 62% 60% 57% 50% 51% 40% 35% 34% 30% 28% 20% 10% 0% < 20 years od 20-29 years old 30 years and older sniffing injecting

So what does this mean?» lot of evidence about changes in routes of administration in the course of a drug-career (e.g. de la Fuente et al. 1997).» route of administration of opioids (outside of OST) differs a lot between countries and regions» Since drug-injecting is regarded as the most harmful route of administration it might be worth looking for interventions that aim to change the route of administration» A well researched intervention to change the route of administration from injecting to ingestion via eating/drinking is OST» assumption that there might be also other possibilities to influence the route of administration (especially avoiding of shifting to IDU)

Systematic literature review with following questions» Which interventions focus on the route of administration (e. g. avoid shifting to IDU from other routes or promote shifting from IDU to other routes of administration)?» How successful are these programmes concerning the reduction of drug-induced deaths?

Factors influencing the route of administration» depression (Cepeda et al. 2012)» longer drug-career (Malekinejad/Vazirian 2012)» homelessness (Roy et al. 2007)» poly-drug use (Emmanuel/Attarad 2006)» lifetime history of sexual violence (Cheng et al. 2006)» an injecting partner (Sherman et al. 2002)» many IDUs in the social network (Koram et al. 2011)» younger age at first heroin use (Neaigus et al. 2006)» school drop-out (Fuller et al. 2002)» belief that injection is more efficient route than smoking or sniffing (Bravo et al. 2003)» prison (Long et al. 2004)» different kinds and purity of heroin or opioids (Hunt et al. 2005)» factors associated with shifting away from injecting to non-injecting routes of administration are:» opioid substitution treatment (Hunt et al. 2005)» concerns about health (Des Jarlais et al. 2007)» social stigmatisation of injecting (Des Jarlais et al. 2007)» vein problems (Bravo et al. 2003)

Possible interventions» The chasing campaign : to promote heroin chasing as an alternative route of drug administration for injectors. (Healthy Option Team/Respect Users Union) no evaluation» Foil distribution: In Australia, the Netherlands, Spain and the UK to promote inhaling among injectors. Evaluation-study (Pizzey/Hunt 2008) reported promising first results. No final evidence statement can be derived» Training programmes to prevent transitions to injecting: The Sniffer programme for intranasal heroin users in New York, reinforced motives for avoiding injecting and developed coping skills (Bridge 2010). Evaluation: significant less injecting than in control group.» A brief intervention for use with current injectors has been developed in UK ( Break the Circle )(not inject in front of non injectors, avoid initiation of others). Prevention of Transition to Injecting project in Australia (Bridge 2010). Although some of the results are promising no final evidence statement can be derived» Australia -Five session programme to promote shifting from IDU to other route of administration. No final evidence

Conclusions» Although the importance of the route of administration for prevention of DRID as well as for prevention of DRD has been reported in literature for 20 years, interventions as well as research on interventions to influence route of administration of opioids other than OST are scarce.» One way to gather more insight into factors influencing the route of administration would be to analyse differences in route of administration between countries.

Many thanks for your attention! alexander.grabenhofer-eggerth@goeg.at